BMS slides after reducing Opdivo/Yervoy expectations

Bristol-Myers Squibb Co. (NYSE:BMY) sank $6.26 (11%) to $49.23 on Friday, shedding about $10.5 billion in market cap, in the

Read the full 207 word article

User Sign In